Taysha Gene Therapies to Participate in Upcoming August Investor Healthcare Conferences

Rhea-AI Summary

Taysha Gene Therapies (Nasdaq: TSHA) announced its participation in two upcoming virtual conferences. The BTIG Virtual Biotechnology Conference will take place on August 9, 2021, at 11:30 am ET, featuring a fireside chat with key executives including the President and CEO, RA Session II, and others. Additionally, the Wedbush Pacgrow Healthcare Virtual Conference is scheduled for August 11, 2021, at 8:35 am ET, where the same executives will participate in a panel discussion. Webcasts for both events will be available on Taysha's corporate website.

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivitol-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in a fireside chat for the BTIG Virtual Biotechnology Conference and a panel for the 2021 Wedbush Pacgrow Healthcare Virtual Conference.

Conferences Details:
Event:	BTIG Virtual Biotechnology Conference
Date:	Monday August 9, 2021
Time:	11:30 am ET
Format:	Fireside chat
Participants:	RA Session II, President, Founder and CEO
	Dr. Suyash Prasad, Chief Medical Officer and Head of R&D
	Kamran Alam, Chief Financial Officer
Event:	2021 Wedbush Pacgrow Healthcare Virtual Conference
Date:	Wednesday August 11, 2021
Time:	8:35 am ET
Format:	Panel discussion
Participants:	RA Session II, President, Founder and CEO

Webcasts for these conferences will be available in the “Events & Media” section of the Taysha corporate website at https://ir.tayshagtx.com/news-events/events-presentations. Archived versions of the webcasts will be available on the website for 60 days.

About Taysha Gene Therapies

Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for potential new cures—with a goal of dramatically improving patients’ lives. More information is available at www.tayshagtx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210802005344/en/

FAQ

What is the date and time of Taysha's participation in the BTIG Virtual Biotechnology Conference?

Taysha Gene Therapies will participate in the BTIG Virtual Biotechnology Conference on August 9, 2021, at 11:30 am ET.

Who are the participants in the BTIG Virtual Biotechnology Conference for Taysha?

Participants include RA Session II, President and CEO, Dr. Suyash Prasad, Chief Medical Officer, and Kamran Alam, Chief Financial Officer.

When is the Wedbush Pacgrow Healthcare Virtual Conference event for Taysha?

The Wedbush Pacgrow Healthcare Virtual Conference is on August 11, 2021, at 8:35 am ET.

What format will Taysha's presentation take at the Wedbush Pacgrow Conference?

Taysha's presentation at the Wedbush Pacgrow Healthcare Conference will be a panel discussion.

Where can I find webcasts for Taysha Gene Therapies' conference participation?

Webcasts for both conferences will be available in the 'Events & Media' section of Taysha's corporate website.